Factor VIII: maximal benefit?
Nour-Eldin
F
F
D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects; D003029:Coagulants / Q000494:pharmacology / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005169:Factor VIII / Q000191:economics / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy* / Q000191:economics; D006801:Humans; D009930:Organic Chemicals
C039584:Bridge anticoagulant neutralizing agent; D003029:Coagulants; D009930:Organic Chemicals; D005169:Factor VIII